Reference
Nathwani D, et al. Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection. Journal of Antimicrobial Chemotherapy : 5 Aug 2014. Available from: URL: http://jac.oxfordjournals.org/content/early/2014/08/02/jac.dku257
Rights and permissions
About this article
Cite this article
Fidaxomicin cost effective vs vancomycin in CDI in Scotland. PharmacoEcon Outcomes News 710, 13 (2014). https://doi.org/10.1007/s40274-014-1486-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1486-7